Date
- Monday, 24 September 2012, All day
Location
- European Medicines Agency, Amsterdam, the Netherlands
This is a joint meeting with representatives from patients', consumers' and healthcare professionals' organisations. The participants are discussing issues in relation to their general involvement in the Agency's activities, giving particular focus to the new pharmacovigilance legislation, communication and information. Registration by invitation only.
Documents
Agenda - Patients' and Consumers' Working Party (PCWP) and Healthcare Professionals' Working Group (HCP WG) joint meeting: September 2012
English (EN) (139.71 KB - PDF)
Minutes of the Patients' and Consumers' Working Party (PCWP) and Healthcare Professionals' Working Group (HCPWG) joint meeting: September 2012
English (EN) (219.22 KB - PDF)
List of participants - Patients' and Consumers' Working Party (PCWP) and Healthcare Professionals' Working Group (HCPWG) joint meeting: September 2012
English (EN) (148.29 KB - PDF)
Presentation - Implementation of the new pharmacovigilance legislation: update on status (Franck Diafouka)
English (EN) (2.21 MB - PDF)
Presentation - Commission call on patient and healthcare representatives for PRAC and CAT (Florian Schmidt)
English (EN) (349.12 KB - PDF)
Presentation - Additional monitoring – proposals on the black symbol for the summary of product characteristics and package leaflet (Ana Sempere)
English (EN) (483.12 KB - PDF)
Presentation - Public hearings (Francois Houyez)
English (EN) (1.34 MB - PDF)
Presentation - Reporting of adverse drug reactions by patients and consumers (Sabine Brosch, Victoria Newbould)
English (EN) (269.44 KB - PDF)
Presentation - Online reporting for patients and healthcare professionals: a practical example (Phil Tregunno)
English (EN) (114.69 KB - PDF)
Presentation - Understanding off-label use and the information needs of patients: a pilot Eurordis survey in rare diseases (Rob Camp, Richard West)
English (EN) (1.31 MB - PDF)
Presentation - Good pharmacovigilance practices (Priya Bahri)
English (EN) (210.37 KB - PDF)
Presentation - Draft good-pharmacovigilance-practice module XV: Safety communications
English (EN) (159.44 KB - PDF)
Presentation - Disseminating European Medicines Agency information (Monika Benstetter, Sarah Weatherley, Christopher Gadd)
English (EN) (413.31 KB - PDF)
Presentation - Communication and dissemination of European Medicines Agency information: perspective from healthcare professionals
English (EN) (995.83 KB - PDF)
Presentation - How does United European Gastroenterology communicate and disseminate information released by the European Medicines Agency? (Michel Delvaux)
English (EN) (380.25 KB - PDF)
Presentation - Dissemination of European Medicines Agency information (Susanna Palkonen)
English (EN) (451.18 KB - PDF)
Presentation - European Medicines Agency information to European Multiple Sclerosis Platform members (Christoph Thalheim)
English (EN) (1.21 MB - PDF)
Presentation - European-public-assessment-report summary template (Daniel Glanville)
English (EN) (1016.95 KB - PDF)
Presentation - Stakeholder perspectives in assessing the benefit-risk balance for medicines (Deborah Ashby, Alain Micaleff)
English (EN) (828.3 KB - PDF)
Presentation - Survey on the communication practices during a pandemic influenza crisis (Ivana Silva)
English (EN) (239.7 KB - PDF)
Presentation - Framework on the interaction between the European Medicines Agency and healthcare professionals (Ivana Silva)
English (EN) (195.64 KB - PDF)
Presentation - Fifth report on the interaction with patients' and consumers' organisations: 2011 (Nathalie Bere)
English (EN) (252.06 KB - PDF)
Presentation - Patients' and Consumers' Working Party and Healthcare Professionals' Working Party work programmes for 2013 (Ivana Silva, Nathalie Bere)
English (EN) (175.37 KB - PDF)